The global rise in anti-microbial resistance with the limited bioavailability and suboptimal pharmacokinetic performance of conventional therapeutics, it has intensified the interest in natural bioenhancer capable of improving therapeutics, having intensified the interest in natural bioenhancer thus capable of improving therapeutic efficacy across infectious and non-infectious disease settings. Cow urine distillate (CUD), an Ayurvedic preparation, has showcased the immunomodulatory, anti-inflammatory, antimicrobial, and bioavailability-enhancing properties. The in-silico investigation explored CUD-derived bioactive constituents as a multi-target bioenhancer, having its key role on vivid and diverse molecular pathways that act in fungal, parasitic, bacterial, viral, inflammatory, and immune-mediated disorders. Computational studies have revealed the CUD phytochemicals and key pathogen targets, like penicillin-binding protein 2a (PBP2a), topoisomerase IV, viral proteases, β-tubulin, and glutathione S-transferase, RNA-dependent RNA polymerase, lanosterol 14-α-demethylase (CYP51), host-regulatory targets such as cyclooxygenase-2 (COX-2), nuclear factor-κB (NF-κB), and Toll-like receptors. Literature suggests that primary constituents, including cinnamic acid, ferulic acid, indole, and hexanoic acid, are evaluated by in silico tools like AutoDock Vina, MOE, and Schrödinger Glide, Molecular Dynamics (MD) simulations to assess binding stability and conformational behavior. Molecular Docking results are indicative of stable binding affinities and in silico ADMET analyses by using SwissADME and pkCSM, predicting favorable oral bioavailability and low toxicity profiles compatible with adjunctive use. Network pharmacology analyses support a polypharmacological mode of action targeting both pathogen survival pathways and host immune-inflammatory signaling. The available in silico evidence proves CUD as a promising multi-target bioenhancer; systematic in vitro and in vivo validation are essential to substantiate its translational potential.